Objective Thyroid-stimulating hormone (TSH) is a growth factor affecting initiation or
progression of papillary thyroid cancer (PTC), which supports TSH suppressive therapy in …

Background Thyrotropin (TSH) is a known thyroid growth factor. Several studies have
suggested its potential role in carcinogenesis and the progression of differentiated thyroid …

Background: During active surveillance (AS), serum thyrotropin (TSH) levels may affect
papillary thyroid microcarcinoma (PTMC) progression. We investigated AS outcomes …

Background Active surveillance (AS) of low‐risk papillary thyroid microcarcinoma (PTMC)
was initiated at Kuma Hospital in 1993 and is gradually spreading worldwide. We assessed …

Background: Recent studies have shown that elevated serum thyrotropin (thyroid-stimulating
hormone [TSH]) concentrations are associated with an increased risk of differentiated thyroid …

Context: Although the prognosis of papillary thyroid microcarcinoma (PTMC) is usually
excellent, the optimal follow-up strategy has never been investigated. Objective: The …

Background The ongoing Multicenter Prospective Cohort Study of Active Surveillance on
Papillary Thyroid Microcarcinoma (MAeSTro) aims to observe the natural course of papillary …

Background: Active surveillance (AS) is an alternative to thyroidectomy for the management
of low-risk papillary thyroid microcarcinoma (PTMC). However, prospective AS data …

110001, PR China 2) Department of Endocrinology and Metabolism, The Endocrine Institute
and The Liaoning Provincial Key Laboratory of Endocrine Diseases, The First Hospital of …

Background: Active surveillance has been introduced as a management option for low-risk
papillary thyroid microcarcinoma (PTMC) due to its mostly indolent course. Methods: This …